期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
药学监护工作中的临床药动学监测和相关咨询 被引量:6
1
作者 余自成 《中国药师》 CAS 2006年第6期555-556,共2页
药学监护(PharmaceuticalCare,PC)的主要目标是实现肯定的治疗结果,包括治愈疾病,消除或减轻疾病症状,阻止或延缓疾病的进程,预防疾病或症状发生,最终达到提高病人生命质量的目的。药师在开展药学监护工作中进行临床药动学监测... 药学监护(PharmaceuticalCare,PC)的主要目标是实现肯定的治疗结果,包括治愈疾病,消除或减轻疾病症状,阻止或延缓疾病的进程,预防疾病或症状发生,最终达到提高病人生命质量的目的。药师在开展药学监护工作中进行临床药动学监测(clinicalpharmacokineticmonitoring,CPM)和提供相关的咨询服务是实现上述目标的重要手段之一。 展开更多
关键词 监护 药动学监测
下载PDF
我院开展临床药学服务工作的做法和体会 被引量:19
2
作者 楼伟建 韩钢 陈惠真 《中华医院管理杂志》 北大核心 2005年第12期842-844,共3页
开展临床药学服务工作的内容包括:临床药师参与查房、药动学监测、药物不良反应监测、 药学信息服务和药物利用度分析。针对临床药学服务工作中遇到的参与查房的困难、临床药师知识结 构的不足、临床药师工作量的考核等,采取了相应的措... 开展临床药学服务工作的内容包括:临床药师参与查房、药动学监测、药物不良反应监测、 药学信息服务和药物利用度分析。针对临床药学服务工作中遇到的参与查房的困难、临床药师知识结 构的不足、临床药师工作量的考核等,采取了相应的措施,以充分发挥临床药师在临床药物治疗和药物 信息服务中的作用。 展开更多
关键词 临床 临床服务 事管理 药动学监测 物利用度分析
原文传递
Determination of hyperoside in rat plasma after intravenous administration by UPLC-MS
3
作者 檀爱民 林萍 张斐 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2013年第6期516-520,共5页
Hyperoside is one of the major components of Hypericum perforatum L. and also present in many plant species such as Abelmoschus manihot (L.) Medik., Ribes nigrum L. and Rosa agrestis Savi (Rosaceae). Because hyper... Hyperoside is one of the major components of Hypericum perforatum L. and also present in many plant species such as Abelmoschus manihot (L.) Medik., Ribes nigrum L. and Rosa agrestis Savi (Rosaceae). Because hyperoside exhibits many biological activities, the pharmacokinetics profile of hyperoside needs to be studied for further elucidating its mechanism of action. A simple method for the determination of hyperoside in rat plasma was developed by using ultra-high performance liquid chromatography coupled with mass spectrometry (UPLC-MS). Only 50 ~tL plasma samples were required for sample preparation. The quantitative detection of hyperoside was accomplished by selected ion monitoring (SIM) in negative ion mode. Hyperoside was analyzed in less than 10 rain. Good linearity was obtained (r2〉0.999) and the intra- and inter-day precision of the method were lower than 15%. Lower limit of quantification (LLOQ) was 4 ng/mL for hyperoside in rat plasma. Our method showed advantage in the lower LLOQ compared with the reported method; furthermore, smaller amount of plasma was needed. The method was successfully applied for the pharmacokinetics study of hyperoside in rat after intravenous administration of hyperoside. 展开更多
关键词 HYPEROSIDE Selected ion monitoring mode Negative ion mode Pharmacokinetics profile
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部